Unleashing the power of half-life to bring a full-life to patients across the world.
0
SCROLL
From Half-Life to Full-Life.
Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China.
About our team
Global management team with decades of experience spanning the discovery, development, production, and logistics of radiopharmaceuticals.
About our pipeline
We attach the radionuclide to the targeting vector (peptide, small molecule, and single domain antibody) which delivers the payload directly to the tumor.
About our technology
Our radiotechnology platform takes a wholistic approach covering production and logistics of radiopharmaceutical drug products.
Press Releases
-
May 10,2024Full-Life Technologies will showcase preclinical data of its NTSR1-targeted RDC program FL-091 in an oral presentation at the 2024 SNMMI Annual Meeting
-
Apr 11,2024Full-Life Technologies Announced the Poster Presentations of preclinical data of its novel PSMA-targeted RDC program 225Ac-FL-020 at the AACR Annual Meeting 2024